Vaccine maker Biological E (BE), on August 17 said it has acquired Akorn India, a subsidiary of US-based Akorn which manufactures speciality generic injectable medicines and vaccines for $10 million in cash. BE said the acquisition will enable the Hyderabad-based company to enhance its manufacturing capabilities and capacities to produce and supply its vaccines and injectable medicines.

(Moneycontrol)